Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial

PURPOSE: Pneumococcal vaccination (13-valent pneumococcal conjugate vaccine [PCV13]) is recommended to cancer patients undergoing systemic chemotherapy. However, the optimal time interval between vaccine administration and initiation of chemotherapy has been little studied in adult patients with sol...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Wonyoung, Kim, Jong Gwang, Beom, Seung-Hoon, Hwang, Jun-Eul, Shim, Hyun-Jung, Cho, Sang-Hee, Shin, Min-Ho, Jung, Sin-Ho, Chung, Ik-Joo, Song, Joon Young, Bae, Woo Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962463/
https://www.ncbi.nlm.nih.gov/pubmed/31291710
http://dx.doi.org/10.4143/crt.2019.189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962463/
https://www.ncbi.nlm.nih.gov/pubmed/31291710
http://dx.doi.org/10.4143/crt.2019.189

Ejemplares similares